The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin

被引：13

作者：

Faaij, RA

Burggraaf, J

Schoemaker, RC

de Greef, R

Cohen, AF

机构：

[1] Ctr Human Drug Res, CHDR, NL-2333 CL Leiden, Netherlands

[2] NV Organon, Oss, Netherlands

来源：

CLINICAL PHARMACOKINETICS | 2002年 / 41卷 / Suppl 2期

关键词：

D O I：

10.2165/00003088-200241002-00004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：27 / 29

页数：3

共 11 条

[1]

BIGGS R, 1972, HUMAN BLOOD COAGULAT

[2] PHARMACOKINETIC AND ANTITHROMBOTIC PROPERTIES OF 2 PENTASACCHARIDES WITH HIGH-AFFINITY TO ANTITHROMBIN-III IN THE RABBIT - COMPARISON WITH CY216 [J].

CARRIE, D ;

CARANOBE, C ;

SAIVIN, S ;

HOUIN, G ;

PETITOU, M ;

LORMEAU, JC ;

VANBOECKEL, C ;

MEULEMAN, D ;

BONEU, B .

BLOOD, 1994, 84 (08) :2571-2577

[3] The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers [J].

Faaij, RA ;

van Griensven, JMT ;

Schoemaker, RC ;

Goggin, T ;

Guenzi, A ;

Kroon, JM ;

Burggraaf, J ;

Cohen, AF .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (01) :25-29

[4]

HOBBELEN PMJ, 1990, THROMB HAEMOSTASIS, V63, P265

[5] Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs [J].

Lieu, C ;

Shi, JA ;

Donat, F ;

Van Horn, R ;

Brian, W ;

Newton, J ;

Delbressine, L ;

Vos, R .

CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) :19-26

[6] Fondaparinux sodium mechanism of action -: Identification of specific binding to purified and human plasma-derived proteins [J].

Paolucci, F ;

Claviés, MC ;

Donat, F ;

Necciari, J .

CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) :11-18

[7] MECHANISM OF ANTITHROMBIN-III INHIBITION OF FACTOR VIIA TISSUE FACTOR ACTIVITY ON CELL-SURFACES - COMPARISON WITH TISSUE FACTOR PATHWAY INHIBITOR FACTOR XA-INDUCED INHIBITION OF FACTOR VIIA TISSUE FACTOR ACTIVITY [J].

RAO, LVM ;

NORDFANG, O ;

HOANG, AD ;

PENDURTHI, UR .

BLOOD, 1995, 85 (01) :121-129

[8] COMPARATIVE EFFECTS OF RANITIDINE AND CIMETIDINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN MAN [J].

TOON, S ;

HOPKINS, KJ ;

GARSTANG, FM ;

ROWLAND, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (02) :165-172

[9] ENOXACIN-WARFARIN INTERACTION - PHARMACOKINETIC AND STEREOCHEMICAL ASPECTS [J].

TOON, S ;

HOPKINS, KJ ;

GARSTANG, FM ;

AARONS, L ;

SEDMAN, A ;

ROWLAND, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (01) :33-41

[10] INVESTIGATIONS INTO THE POTENTIAL EFFECTS OF MULTIPLE DOSE KETOROLAC ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF RACEMIC WARFARIN [J].

TOON, S ;

HOLT, BL ;

MULLINS, FGP ;

BULLINGHAM, R ;

AARONS, L ;

ROWLAND, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) :743-750

← 1 2 →